These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 10767048)

  • 1. Evaluation of clinical studies of the efficacy of therapeutic apheresis.
    Vamvakas EC
    J Clin Apher; 2000; 15(1-2):6-17. PubMed ID: 10767048
    [No Abstract]   [Full Text] [Related]  

  • 2. Publication bias: its implications for clinical pharmacology.
    Levy G
    Clin Pharmacol Ther; 1992 Aug; 52(2):115-9. PubMed ID: 1505146
    [No Abstract]   [Full Text] [Related]  

  • 3. Statistical management of data in clinical research.
    Fleiss JL; Kingman A
    Crit Rev Oral Biol Med; 1990; 1(1):55-66. PubMed ID: 2101261
    [No Abstract]   [Full Text] [Related]  

  • 4. Randomisation and baseline comparisons in clinical trials.
    Altman DG; Doré CJ
    Lancet; 1990 Jan; 335(8682):149-53. PubMed ID: 1967441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bias control in clinical trials: masking or blinding.
    Galvez-Olortegui JK; Gonzales-Saldaña J; Garcia-Gomez I; Silva-Ocas I; Gutierrez-Arana J; Galvez-Olortegui T; Condor-Rojas YC
    Medwave; 2015 Dec; 15(11):e6349. PubMed ID: 26731671
    [No Abstract]   [Full Text] [Related]  

  • 6. The clinician as investigator: participating in clinical trials in the practice setting: Appendix 1: fundamentals of study design.
    Lader EW; Cannon CP; Ohman EM; Newby LK; Sulmasy DP; Barst RJ; Fair JM; Flather M; Freedman JE; Frye RL; Hand MM; Jesse RL; Van de Werf F; Costa F;
    Circulation; 2004 Jun; 109(21):e302-4. PubMed ID: 15173052
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapeutic apheresis in autoimmune and rheumatic diseases.
    Koo AP
    J Clin Apher; 2000; 15(1-2):18-27. PubMed ID: 10767049
    [No Abstract]   [Full Text] [Related]  

  • 8. Fool's gold? Why blinded trials are not always best.
    Anand R; Norrie J; Bradley JM; McAuley DF; Clarke M
    BMJ; 2020 Jan; 368():l6228. PubMed ID: 31964628
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical trials: the gold standard for evaluation of therapy.
    Meinert CL
    Ophthalmology; 1996 Jun; 103(6):869-70. PubMed ID: 8643240
    [No Abstract]   [Full Text] [Related]  

  • 10. Reducing risk and improving efficacy of clinical trials: the adaptive design.
    Dangi-Garimella S
    Am J Manag Care; 2014 Aug; 20(11 Spec No.):E8. PubMed ID: 25618150
    [No Abstract]   [Full Text] [Related]  

  • 11. Can non-randomized trials be considered to be equivalent to randomized trials in forensic mental health?
    Leese M
    Crim Behav Ment Health; 2005; 15(2):121-2. PubMed ID: 16470506
    [No Abstract]   [Full Text] [Related]  

  • 12. Blinding: an essential component in decreasing risk of bias in experimental designs.
    Forbes D
    Evid Based Nurs; 2013 Jul; 16(3):70-1. PubMed ID: 23696228
    [No Abstract]   [Full Text] [Related]  

  • 13. The Canadian Apheresis Group and therapeutic plasma exchange.
    Rock G; Herbert C
    Transfus Sci; 1999 Jun; 20(3):145-50. PubMed ID: 10623355
    [No Abstract]   [Full Text] [Related]  

  • 14. Issues in subgroup analyses and meta-analyses of clinical trials.
    Bigger JT
    J Cardiovasc Electrophysiol; 2003 Sep; 14(9 Suppl):S6-8. PubMed ID: 12950510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does study design explain the relationship between conflict of interest and positive outcome in clinical trials in psychiatry?
    Wu Y; Deboeck P; Joseph M; Hwang C; Perlis CS; Perlis RH
    J Clin Psychopharmacol; 2009 Dec; 29(6):609-11. PubMed ID: 19910733
    [No Abstract]   [Full Text] [Related]  

  • 16. [Quality assessment of therapeutic clinical trials].
    Selbmann HK; Meisner C
    Internist (Berl); 2000 Apr; 41(4):344-8. PubMed ID: 10798182
    [No Abstract]   [Full Text] [Related]  

  • 17. Blinding during data analysis and writing of manuscripts.
    Gøtzsche PC
    Control Clin Trials; 1996 Aug; 17(4):285-90; discussion 290-3. PubMed ID: 8889343
    [No Abstract]   [Full Text] [Related]  

  • 18. Limitations of double-blind trials.
    Double DB
    Br J Psychiatry; 1990 Aug; 157():300. PubMed ID: 2224388
    [No Abstract]   [Full Text] [Related]  

  • 19. Validity versus generalizability in clinical trial design and conduct.
    Hennekens CH; Buring JE
    J Card Fail; 1998 Sep; 4(3):239-41. PubMed ID: 9754597
    [No Abstract]   [Full Text] [Related]  

  • 20. [Basic principles of clinical trials--what, how, and why?].
    Unnebrink K; Pritsch M
    Med Klin (Munich); 1999 Aug; 94(8):458-64. PubMed ID: 10495627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.